My Lung Cancer tumor markers are rising — what does this mean
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Rising Lung Cancer Tumor Markers
I understand this is concerning news. Let me help you understand what rising tumor markers generally mean and what questions to ask your care team.
What Tumor Markers Tell Us
Tumor markers are substances (usually proteins) that cancer cells produce or that your body makes in response to cancer. When these markers are rising, it typically suggests:
- Increased cancer activity — More cancer cells may be present or growing
- Possible treatment response changes — Your current treatment may need adjustment
- Need for further evaluation — Your doctor will want to investigate what's happening
Rising markers don't automatically mean your situation is worsening, but they do signal that your care team needs to take action and reassess your treatment plan.
How Doctors Respond to Rising Markers
According to NCCN Guidelines for Patients: Metastatic Non-Small Cell Lung Cancer, when tumor markers rise, oncologists typically:
- Review imaging studies (CT scans, PET scans) to see if tumors are actually growing
- Assess your symptoms — Are you experiencing new or worsening symptoms?
- Evaluate current treatment effectiveness — Is your current therapy still working?
- Consider next steps — This might include changing treatment, adding therapy, or adjusting your current plan
Critical Questions to Ask Your Oncology Team
Since your markers are rising, these specific questions will help you understand your situation:
-
"Which tumor marker(s) are rising, and by how much?" — Different markers have different meanings, and the rate of increase matters.
-
"Do my imaging studies (CT/PET scans) show tumor growth, or is this marker change alone?" — Imaging is often more reliable than markers alone for assessing treatment response.
-
"What does this mean for my current treatment plan?" — Will you continue, change, or add to your current therapy?
-
"What is your recommended next step, and what is the reasoning behind it?" — Understanding the clinical logic helps you make informed decisions.
-
"How often should we monitor these markers going forward?" — This helps you know what to expect and when to expect results.
Important Context
Your oncologist will determine the most appropriate response based on:
- Your complete clinical picture (imaging, symptoms, overall health)
- The specific markers that are rising
- Your current treatment and how long you've been on it
- Your goals of care
Rising markers are a signal to act, not a final diagnosis of treatment failure. Many patients have rising markers that respond well to treatment adjustments.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Non-Small Cell Lung Cancer (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What are the latest chemotherapy treatments for lung cancer in 2026
I appreciate your question about current treatment options. Let me explain what the latest evidence shows about chemotherapy for lung cancer, based on
What specific chemotherapy drugs are used for lung cancer and how do they work
I'm glad you're learning about treatment options. Let me explain the chemotherapy drugs commonly used for lung cancer and their mechanisms of action.
What are the common chemotherapy drugs and treatments for lung cancer
I'm glad you're learning about lung cancer treatment options. Let me explain the chemotherapy drugs and approaches that are commonly used, based on cu